Science Explorer Back to mapMap
Discussion
Researcher · Ospedale Garibaldi · Italy

Fiorenza Latteri

Fiorenza Latteri publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Lung Cancer Research Studies.

OpenAlex
World rank
#5,092,532
of 7,710,434 ranked researchers
Rank in Italy
#171,176
of 242,206
Works
20
Citations
174
Citations per work
8.7
h-index
5
i10-index 5Top 85% in Pulmonary and Respiratory Medicine
Fiorenza Latteri

What does Fiorenza Latteri research?

Fiorenza Latteri's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (3%).

Health Sciences: 17 works · 83.3% of their workMedicine: 17 works · 83.3% of their workPulmonary and Respiratory Medicine: 8 works · 40.0% of their workOncology: 6 works · 30.0% of their workSurgery: 2 works · 8.3% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 3.3% of their workHepatology: 0 works · 1.7% of their workEverything else: 3 works · 13.4% of their workLife Sciences: 1 works · 3.3% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 3.3% of their workMolecular Biology: 1 works · 3.3% of their workTHEIR WORKFiorenza Latteri20works
Life Sciences3%Health Sciences83%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1783.3%
  2. Everything else313.4%
    1. Biochemistry, Genetics and Molecular Biology13.3%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology30% of their works
  3. 3Surgery8% of their works
  4. 4Radiology, Nuclear Medicine and Imaging3% of their works
  5. 5Molecular Biology3% of their works
  6. 6Hepatology2% of their works

Research topics

Which keywords describe Fiorenza Latteri's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Chemotherapy, Immunotherapy, Chemotherapy-Induced Peripheral Neuropathy and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Clinical Trials182 topics
  2. Targeted Therapy182 topics
  3. ALK Inhibitors131 topic
  4. EGFR Mutations131 topic
  5. Chemotherapy124 topics
  6. Immunotherapy72 topics
  7. Chemotherapy-Induced Peripheral Neuropathy51 topic
  8. Genomic Profiles51 topic
  9. Small-Cell Lung Cancer51 topic
  10. Taxanes51 topic
  11. Cetuximab31 topic
  12. KRAS Mutations31 topic
  13. BAP1 mutations21 topic
  14. Breast Cancer21 topic
  15. CT Screening21 topic
  16. HER221 topic
  17. Immune Checkpoint Blockade21 topic
  18. Lung Cancer21 topic
  19. Malignant Pleural Mesothelioma21 topic
  20. PD-1 and PD-L121 topic

Where does Fiorenza Latteri work?

Fiorenza Latteri's main affiliation in the publication record is Ospedale Garibaldi, Italy.

How many publications and citations does Fiorenza Latteri have?

OpenAlex counts 20 works and 174 citations for Fiorenza Latteri, an h-index of 5, ranking #5,092,532 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fiorenza Latteri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.